Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00790608
Recruitment Status :
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Must have given written informed consent
Must be ≥ 18 years of age and not of child bearing potential
Must have an ulcer in which the presence of MRSA has been identified, but which is not clinically infected
Must have an ulcer size not to extend beyond the inner borders of the dressing
Is a female of child bearing years or who could become pregnant
Is < 18 years of age
Has an clinically infected skin ulcer
Has a ulcer that is being treated with a topical antimicrobial agent or has been treated with a topical antimicrobial agent during 3 days prior to enrolment
Has been using systemic antibiotics during 7 days prior to enrolment into this study
Has an ulcer which is identified as malignant in origin (e.g. Marjolin's ulcer)
Has an ulcer size beyond the inner borders of the dressing
Is septic or has other signs of an invasive infection
Has used any investigational drug within 30 days preceding study participation.
Suffers from a condition, which, in the opinion of the Investigator, would compromise his or her safety.
Suffers from a condition which, in the opinion of the Investigator, would compromise the quality of the data.
Has a known allergy to any of the products that are part of this protocol
Suffers from a condition which, in the opinion of the Investigator, would seriously interfere negatively with the normal parameters of immune response to an infection.
Is using any of the prohibited concomitant medications or treatments